Show simple item record

dc.contributor.authorMarren, Shannon Mary
dc.date.accessioned2018-10-11T08:49:53Z
dc.date.issued2018-08-15
dc.description.abstractType 1 diabetes was thought to be a disease of absolute insulin deficiency. However, recent evidence has shown that most people with Type 1 diabetes have persistent endogenous insulin production, even those with long disease duration. Close to diagnosis preserved beta cell function is associated with reduced HbA1c, hypoglycaemia and complication rates. However, very little is known about the clinical impact of persistent endogenous insulin in long duration diabetes. This thesis aims to assess the clinical impact of preserved beta cell function in long duration type 1 diabetes. During this analysis we identified the potential for glucagon to be used as a biomarker of hypoglycaemic risk. Intensive treatment is an integral part of diabetes management and is key to reducing the risk of both development and progression of microvascular complications. However, treatment induced hypoglycaemia poses a significant barrier to intensive treatment. Currently, prediction of those most at risk of hypoglycaemia is based on clinical information, such as diabetes duration, with no biomarkers used to assess hypoglycaemic risk. As such, this finding prompted an additional aim: to investigate the relationship between meal stimulated glucagon and hypoglycaemia in long duration type 1 diabetes. In Chapter 1 I review current evidence on the role and importance of persistent beta cell function in type 1 diabetes. In Chapter 2 I outline the methods of the TIGI Study, which provided the data for this project. In Chapter 3 I demonstrate that preserved beta cell function is associated with significantly reduced reported hypoglycaemia in long duration type 1 diabetes. In Chapter 4 I show that higher meal stimulated glucagon is associated with reduced hypoglycaemia rate in long duration type 1 diabetes, independent of HbA1c, C-peptide and disease duration. Chapter 5 discusses the findings of Chapters 3 and 4 and highlights areas for future research.en_GB
dc.identifier.urihttp://hdl.handle.net/10871/34249
dc.language.isoenen_GB
dc.publisherUniversity of Exeteren_GB
dc.subjectType 1 diabetes, C-peptide, Hypoglycaemia, Glucagonen_GB
dc.titleClinical implications of persistent beta cell function in long duration type 1 diabetesen_GB
dc.typeThesis or dissertationen_GB
dc.date.available2018-10-11T08:49:53Z
dc.contributor.advisorOram, Richard
dc.contributor.advisorJones, Angus
dc.contributor.advisorKnight, Bridget
dc.publisher.departmentUniversity of Exeter Medical Schoolen_GB
dc.type.degreetitleMbyRes in Medical Studiesen_GB
dc.type.qualificationlevelMasters Degreeen_GB
dc.type.qualificationnameMbyResen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record